Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.45 |
| ▸ | CA12 | O43570 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | CA7 | P43166 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | PTPRB | P23467 | 1/20 | 0.34 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.33 |
| ▸ | MME | P08473 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | GRIA1 | P42261 | 3/20 | 0.32 |
| ▸ | ESRRB | O95718 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL575986 | 0.84 | SLC22A6 (0.34) | CA14CA12SLC22A6 | |
| SCHEMBL2591216 | 0.80 | CA14 (0.43) | CA14CA12SMN1; SMN2CA7CA9 | |
| SCHEMBL4904213 | 0.80 | CA14 (0.43) | CA14CA12SMN1; SMN2CA7CA9 | |
| SCHEMBL4372490 | 0.80 | CA14 (0.43) | CA14CA12SMN1; SMN2CA7CA9 | |
| SCHEMBL31247919 | 0.80 | CA14 (0.43) | CA14CA12SMN1; SMN2CA7CA9 | |
| SCHEMBL19963061 | 0.77 | CA14 (0.40) | CA14CA12SMN1; SMN2CA7CA9 | |
| SCHEMBL575987 | 0.77 | NAAA (0.31) | SLC22A6 | |
| SCHEMBL16369139 | 0.77 | CA12 (0.38) | CA14CA12CA7KMT2ASLC22A6 | |
| SCHEMBL3766175 | 0.76 | CA14 (0.39) | CA14CA12SMN1; SMN2CA7CA9 | |
| SCHEMBL1786590 | 0.76 | CA14 (0.39) | CA14CA12SMN1; SMN2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1592733-B1 | MICROSPHERES | AKZO NOBEL NV (NL) | 2009-07-08 | — | — | EP | claimed |
| CN-100354346-C | Microspheres | AKZO NOBEL NV (NL) | 2007-12-12 | — | — | CN | claimed |
| CN-1738853-A | Microspheres | AKZO NOBEL NV (NL) | 2006-02-22 | — | — | CN | claimed |
| EP-1592733-A1 | MICROSPHERES | Akzo Nobel N.V. (NL) | 2005-11-09 | — | — | EP | claimed |
| US-20040249005-A1 | eliminating residual monomers such as (meth)acrylonitrile from thermoplastic expandable microspheres of a thermoplastic polymer shell encapsulating a propellant, by contacting with oxo acids of sulfur such as a bisulfite to form 2-cyano-ethanesulfonic acid for example | AKZO NOBEL N.V. (NL) | 2004-12-09 | — | — | US | claimed |
| WO-2004072160-A1 | MICROSPHERES | AKZO NOBEL N.V. (NL) | 2004-08-26 | — | — | WO | claimed |
| EP-1592733-B1 | MICROSPHERES | AKZO NOBEL NV (NL) | 2009-07-08 | — | — | EP | disclosed |
| CN-100354346-C | Microspheres | AKZO NOBEL NV (NL) | 2007-12-12 | — | — | CN | disclosed |
| CN-1738853-A | Microspheres | AKZO NOBEL NV (NL) | 2006-02-22 | — | — | CN | disclosed |
| EP-1592733-A1 | MICROSPHERES | Akzo Nobel N.V. (NL) | 2005-11-09 | — | — | EP | disclosed |
| US-20040249005-A1 | eliminating residual monomers such as (meth)acrylonitrile from thermoplastic expandable microspheres of a thermoplastic polymer shell encapsulating a propellant, by contacting with oxo acids of sulfur such as a bisulfite to form 2-cyano-ethanesulfonic acid for example | AKZO NOBEL N.V. (NL) | 2004-12-09 | — | — | US | disclosed |
| WO-2004072160-A1 | MICROSPHERES | AKZO NOBEL N.V. (NL) | 2004-08-26 | — | — | WO | disclosed |
| CN-1096448-C | Farnesyl transferase inhibitors, its preparation and medicine composition thereof | RHONE POULENC RORER SA (FR) | 2002-12-18 | — | — | CN | disclosed |
| CN-1190389-A | Novel farnesyl transferase inhibitors, process for their preparation and pharmaceutical compositions containing them | RHONE POULENC RORER SA (FR) | 1998-08-12 | — | — | CN | disclosed |